Thomas J. Herzfeld Advisors, Inc. Biomarin Pharmaceutical Inc Transaction History

Thomas J. Herzfeld Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$80.35 - $93.9 $19,203 - $22,442	-239 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$84.2 - $98.62 $1,010 - $1,183	-12 Reduced 4.78%	239 $21,000
Q4 2018 Feb 14, 2019	BUY	$80.14 - $106.07 $3,686 - $4,879	46 Added 22.44%	251 $21,000
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $10,425 - $11,734	-111 Reduced 35.13%	205 $20,000
Q1 2018 May 15, 2018	BUY	$77.67 - $92.63 $8,155 - $9,726	105 Added 49.76%	316 $26,000
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $15,263 - $17,979	-189 Reduced 47.25%	211 $19,000
Q2 2017 Aug 14, 2017	BUY	N/A	400	400 $36,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Thomas J. Herzfeld Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Thomas J. Herzfeld Advisors, Inc. with notifications on news.